HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden.

AbstractBACKGROUND:
Central nervous system (CNS) human immunodeficiency virus (HIV) infection and immune activation lead to brain injury and neurological impairment. Although HIV enters the nervous system soon after transmission, the magnitude of infection and immunoactivation within the CNS during primary HIV infection (PHI) has not been characterized.
METHODS:
This cross-sectional study analyzed cerebrospinal fluid (CSF) and blood from 96 participants with PHI and compared them with samples from neuroasymptomatic participants with chronic infection and ≥ 200 or < 200 blood CD4 T cells/μL, and with samples from HIV-seronegative participants with respect to CSF and plasma HIV RNA, CSF to serum albumin ratio, and CSF white blood cell counts (WBC), neopterin levels, and concentrations of chemokines CXCL10 and CCL2.
RESULTS:
The PHI participants (median 77 days post transmission) had CSF HIV RNA, WBC, neopterin, and CXCL10 concentrations similar to the chronic infection participants but uniquely high albumin ratios. 18 participants had ≤ 100 copies/mL CSF HIV RNA, which was associated with low CSF to plasma HIV ratios and levels of CSF inflammation lower than in other PHI participants but higher than in HIV-seronegative controls.
CONCLUSIONS:
Prominent CNS infection and immune activation is evident during the first months after HIV transmission, though a proportion of PHI patients demonstrate relatively reduced CSF HIV RNA and inflammation during this early period.
AuthorsSerena Spudich, Magnus Gisslen, Lars Hagberg, Evelyn Lee, Teri Liegler, Bruce Brew, Dietmar Fuchs, Giuseppe Tambussi, Paola Cinque, Frederick M Hecht, Richard W Price
JournalThe Journal of infectious diseases (J Infect Dis) Vol. 204 Issue 5 Pg. 753-60 (Sep 01 2011) ISSN: 1537-6613 [Electronic] United States
PMID21844301 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • Chemokine CCL2
  • Chemokine CXCL10
  • RNA, Viral
  • Serum Albumin
  • Neopterin
Topics
  • Adult
  • Biomarkers (blood, cerebrospinal fluid)
  • Central Nervous System (immunology)
  • Chemokine CCL2 (cerebrospinal fluid)
  • Chemokine CXCL10 (cerebrospinal fluid)
  • Chronic Disease
  • Cross-Sectional Studies
  • Female
  • HIV Infections (blood, cerebrospinal fluid, immunology)
  • HIV Seronegativity
  • HIV-1 (immunology)
  • Humans
  • Leukocyte Count
  • Male
  • Neopterin (cerebrospinal fluid)
  • RNA, Viral (blood, cerebrospinal fluid)
  • Serum Albumin (metabolism)
  • Time Factors
  • Viral Load (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: